Entrepreneurial Thought Leaders (ETL) Kim Popovits (Genomic Health) - Strategies in the Biopharmaceutical Industry
21 snips
Feb 8, 2006 Kim Popovits, President and COO of Genomic Health, Inc., brings a wealth of experience from her time at Genentech. She delves into the transformative impact of molecular diagnostics in cancer care, sharing her leadership journey and the hurdles faced in launching innovative products. Kim highlights the critical engagement strategies with oncologists and the complexities of market research and reimbursement in the biopharmaceutical landscape. Her insights underscore the importance of patient care and expanding personalized medicine beyond breast cancer.
AI Snips
Chapters
Transcript
Episode notes
Building an All-Star Team
- Build an all-star team with diverse expertise.
- Focus on recruiting A-players who excel in their respective roles.
Shared Passion and Values
- Share a common passion and values within your team.
- This shared purpose helps in decision-making and navigating challenges.
Oncotype DX Test
- Genomic Health's Oncotype DX test analyzes a 21-gene panel.
- It provides a recurrence score, indicating the likelihood of cancer recurrence, aiding treatment decisions.